DCNN — Digicann Ventures Share Price
- CA$0.27m
- CA$13.66m
- CA$0.67m
- 55
- 79
- 61
- 71
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | n/a | ||
Price to Tang. Book | n/a | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 0.47 | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | n/a | ||
Return on Equity | -467.32% | ||
Operating Margin | -2677.44% |
Financial Summary
Year End 31st Dec | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023E | 2024E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | CA$m | n/a | 0 | 1.49 | 0.93 | 0.67 | n/a | n/a | n/a |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Digicann Ventures Inc., formerly Agra Ventures Ltd., is a Canada-based diversified company focused on the international cannabis industry. The Company is engaged in the cultivation, distribution and marketing of cannabis and cannabis-infused products around the world. It has a portfolio of licensed upstream, downstream, and product formulation assets. Its primary asset in Canada is Boundary Bay Cannabis, a cannabis greenhouse facility focused on the cultivation of high-potency cannabis. The Company's wholly owned subsidiary, Farmako GmbH (Farmako), is a distributor of medical cannabis. Farmako distributes the products in its network of German pharmacies. Its products have Farmako's branding. The products initially include high potency tetrahydrocannabinol (THC) flower and balanced THC and cannabidiol (CBD) flower. Farmako has product distribution operations in Germany and in the United Kingdom.
Directors
- Brandon Boddy CHM
- Elise Coppens CEO
- Fiona Fitzmaurice CFO
- Jerry Habuda IND
- Christopher Hornung IND
- Brian O'Neil IND
- Joseph Perino IND
- Last Annual
- December 31st, 2022
- Last Interim
- September 30th, 2023
- Incorporated
- June 24th, 2004
- Public Since
- March 1st, 2006
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- Canadian Securities Exchange
- Shares in Issue
- 17,856,672
- Address
- Suite 810 - 789 West Pender Street, VANCOUVER, V6C 1H2
- Web
- http://digicann.io/
- Phone
- +1 6046822928
- Auditors
- Baker Tilly WM LLP
Upcoming Events for DCNN
Q1 2024 Digicann Ventures Inc Earnings Release
Agra Ventures Ltd Annual Shareholders Meeting
Q2 2024 Digicann Ventures Inc Earnings Release
Similar to DCNN
4Front Ventures
Canadian Securities Exchange
Ascend Wellness Holdings
Canadian Securities Exchange
Atlas Global Brands
Canadian Securities Exchange
Ayr Wellness
Canadian Securities Exchange
Braxia Scientific
Canadian Securities Exchange
FAQ
As of Today at 19:06 UTC, shares in Digicann Ventures are trading at CA$0.02. This share price information is delayed by 15 minutes.
Shares in Digicann Ventures last closed at CA$0.02 and the price had moved by +200% over the past 365 days. In terms of relative price strength the Digicann Ventures share price has outperformed the Toronto Stock Exchange 300 Composite Index by +182.88% over the past year.
The overall consensus recommendation for Digicann Ventures is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Digicann Ventures does not currently pay a dividend.
Digicann Ventures does not currently pay a dividend.
Digicann Ventures does not currently pay a dividend.
To buy shares in Digicann Ventures you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of CA$0.02, shares in Digicann Ventures had a market capitalisation of CA$0.27m.
Here are the trading details for Digicann Ventures:
- Country of listing: Canada
- Exchange: CNX
- Ticker Symbol: DCNN
Based on an overall assessment of its quality, value and momentum Digicann Ventures is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Digicann Ventures. Over the past six months, its share price has underperformed the Toronto Stock Exchange 300 Composite Index by -13.84%.
As of the last closing price of CA$0.02, shares in Digicann Ventures were trading -12.6% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Digicann Ventures PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at CA$0.02.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Digicann Ventures' management team is headed by:
- Brandon Boddy - CHM
- Elise Coppens - CEO
- Fiona Fitzmaurice - CFO
- Jerry Habuda - IND
- Christopher Hornung - IND
- Brian O'Neil - IND
- Joseph Perino - IND